This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hjorth, S. A. Articles by Schwartz, T. W. Search for Related Content PubMed PubMed Citation Articles by Hjorth, S. A. Articles by Schwartz, T. W.

Constitutive Activity of Glucagon Receptor Mutants

Laboratory for Molecular Pharmacology (S.A.H., C.Ø., T.W.S.) Department of Pharmacology
Department of Anatomy (C.Ø.) The Panum Institute DK-2200 Copenhagen N, Denmark

Increased constitutive activity has been observed in the PTH receptor in association with naturally occurring mutations of two residues that are conserved between members of the glucagon/vasoactive intestinal peptide/calcitonin 7TM receptor family. Here, the corresponding residues of the glucagon receptor, His¹⁷⁸ and Thr³⁵², were probed by mutagenesis. An elevated level of basal cAMP production was observed after the exchange of His¹⁷⁸ into Arg, but not for the exchange into Lys, Ala, or Glu. However, for all of these His¹⁷⁸ substitutions, an increased binding affinity for glucagon was observed [dissociation constant (K_d) ranging from 1.1–6.4 nM, wild type: K_d = 12.0 nM]. A further increase in cAMP production was observed for the [H178R] construct upon stimulation with glucagon, albeit the EC₅₀ surprisingly was increased approximately 10-fold relative to the wild-type receptor. Substitution of Thr³⁵², located at the intracellular end of transmembrane segment VI, with Ala led to a slightly elevated basal cAMP level, while the introduction of Pro or Ser at this position affected rather the binding affinity of glucagon or the EC₅₀ for stimulation of cAMP production. The large extracellular segment, which is essential for glucagon binding, was not required for constitutive activation of the glucagon receptor as the introduction of the [H178R] mutation into an N-terminally truncated construct exhibited an elevated basal level of cAMP production. The analog des-His¹-[Glu⁹]glucagon amide, which in vivo is a glucagon antagonist, was an agonist on both the wild-type and the [H178R] receptor and did not display any activity as an inverse agonist. It is concluded that the various phenotypes displayed by the constitutively active glucagon receptor mutants reflect the existence of multiple agonist-preferring receptor conformers, which include functionally active as well as inactive states. This view agrees with a recent multi-state extension of the ternary complex model for 7TM receptor activation.

This article has been cited by other articles:

				S. Mueller, G. Kleinau, H. Jaeschke, S. Neumann, G. Krause, and R. Paschke Significance of Ectodomain Cysteine Boxes 2 and 3 for the Activation Mechanism of the Thyroid-stimulating Hormone Receptor J. Biol. Chem., October 20, 2006; 281(42): 31638 - 31646. [Abstract] [Full Text] [PDF]

				U. Ringkananont, J. Van Durme, L. Montanelli, F. Ugrasbul, Y. M. Yu, R. E. Weiss, S. Refetoff, and H. Grasberger Repulsive Separation of the Cytoplasmic Ends of Transmembrane Helices 3 and 6 Is Linked to Receptor Activation in a Novel Thyrotropin Receptor Mutant (M626I) Mol. Endocrinol., April 1, 2006; 20(4): 893 - 903. [Abstract] [Full Text] [PDF]

				R. C. Gensure, N. Shimizu, J. Tsang, and T. J. Gardella Identification of a Contact Site for Residue 19 of Parathyroid Hormone (PTH) and PTH-Related Protein Analogs in Transmembrane Domain Two of the Type 1 PTH Receptor Mol. Endocrinol., December 1, 2003; 17(12): 2647 - 2658. [Abstract] [Full Text] [PDF]

				K. Chakir, Y. Xiang, D. Yang, S.-J. Zhang, H. Cheng, B. K. Kobilka, and R.-P. Xiao The Third Intracellular Loop and the Carboxyl Terminus of {beta}2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor Mol. Pharmacol., November 1, 2003; 64(5): 1048 - 1058. [Abstract] [Full Text] [PDF]

				S. Runge, C. Gram, H. Brauner-Osborne, K. Madsen, L. B. Knudsen, and B. S. Wulff Three Distinct Epitopes on the Extracellular Face of the Glucagon Receptor Determine Specificity for the Glucagon Amino Terminus J. Biol. Chem., July 18, 2003; 278(30): 28005 - 28010. [Abstract] [Full Text] [PDF]

				M. Haywood, N. Tymchenko, J. Spaliviero, A. Koch, M. Jimenez, J. Gromoll, M. Simoni, V. Nordhoff, D. J. Handelsman, and C. M. Allan An Activated Human Follicle-Stimulating Hormone (FSH) Receptor Stimulates FSH-Like Activity in Gonadotropin-Deficient Transgenic Mice Mol. Endocrinol., November 1, 2002; 16(11): 2582 - 2591. [Abstract] [Full Text] [PDF]

				Y.-X. Tao, D. Mizrachi, and D. L. Segaloff Chimeras of the Rat and Human FSH Receptors (FSHRs) Identify Residues that Permit or Suppress Transmembrane 6 Mutation-Induced Constitutive Activation of the FSHR via Rearrangements of Hydrophobic Interactions Between Helices 6 and 7 Mol. Endocrinol., August 1, 2002; 16(8): 1881 - 1892. [Abstract] [Full Text] [PDF]

				M. Ascoli, F. Fanelli, and D. L. Segaloff The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective Endocr. Rev., April 1, 2002; 23(2): 141 - 174. [Abstract] [Full Text] [PDF]

				V. Vlaeminck-Guillem, S.-C. Ho, P. Rodien, G. Vassart, and S. Costagliola Activation of the cAMP Pathway by the TSH Receptor Involves Switching of the Ectodomain from a Tethered Inverse Agonist to an Agonist Mol. Endocrinol., April 1, 2002; 16(4): 736 - 746. [Abstract] [Full Text] [PDF]

				S. M. Nielsen, L. Z. Nielsen, S. A. Hjorth, M. H. Perrin, and W. W. Vale Constitutive activation of tethered-peptide/ corticotropin-releasing factor receptor chimeras PNAS, August 29, 2000; 97(18): 10277 - 10281. [Abstract] [Full Text] [PDF]

				Y.-X. Tao, A. N. Abell, X. Liu, K. Nakamura, and D. L. Segaloff Constitutive Activation of G Protein-Coupled Receptors as a Result of Selective Substitution of a Conserved Leucine Residue in Transmembrane Helix III Mol. Endocrinol., August 1, 2000; 14(8): 1272 - 1282. [Abstract] [Full Text]

				S. A. Hinke, J. A. Pospisilik, H.-U. Demuth, S. Mannhart, K. Kuhn-Wache, T. Hoffmann, E. Nishimura, R. A. Pederson, and C. H. S. McIntosh Dipeptidyl Peptidase IV (DPIV/CD26) Degradation of Glucagon. CHARACTERIZATION OF GLUCAGON DEGRADATION PRODUCTS AND DPIV-RESISTANT ANALOGS J. Biol. Chem., February 11, 2000; 275(6): 3827 - 3834. [Abstract] [Full Text] [PDF]

				U. Gether Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors Endocr. Rev., February 1, 2000; 21(1): 90 - 113. [Abstract] [Full Text]

				A. M. Cypess, C. G. Unson, C.-R. Wu, and T. P. Sakmar Two Cytoplasmic Loops of the Glucagon Receptor Are Required to Elevate cAMP or Intracellular Calcium J. Biol. Chem., July 2, 1999; 274(27): 19455 - 19464. [Abstract] [Full Text] [PDF]

				S. G.F. Rasmussen, A. D. Jensen, G. Liapakis, P. Ghanouni, J. A. Javitch, and U. Gether Mutation of a Highly Conserved Aspartic Acid in the beta 2 Adrenergic Receptor: Constitutive Activation, Structural Instability, and Conformational Rearrangement of Transmembrane Segment 6 Mol. Pharmacol., July 1, 1999; 56(1): 175 - 184. [Abstract] [Full Text]

				F. Fanelli, P. Barbier, D. Zanchetta, P. G. de Benedetti, and B. Chini Activation Mechanism of Human Oxytocin Receptor: A Combined Study of Experimental and Computer-Simulated Mutagenesis Mol. Pharmacol., July 1, 1999; 56(1): 214 - 225. [Abstract] [Full Text]

				M. D. Luck, P. H. Carter, and T. J. Gardella The (1-14) Fragment of Parathyroid Hormone (PTH) Activates Intact and Amino-Terminally Truncated PTH-1 Receptors Mol. Endocrinol., May 1, 1999; 13(5): 670 - 680. [Abstract] [Full Text]

				A. N. Abell, D. J. McCormick, and D. L. Segaloff Certain Activating Mutations within Helix 6 of the Human Luteinizing Hormone Receptor May Be Explained by Alterations That Allow Transmembrane Regions to Activate Gs Mol. Endocrinol., December 1, 1998; 12(12): 1857 - 1869. [Abstract] [Full Text]

				C. G. Unson, C.-R. Wu, T. P. Sakmar, and R. B. Merrifield Selective Stabilization of the High Affinity Binding Conformation of Glucagon Receptor by the Long Splice Variant of Galpha s J. Biol. Chem., July 7, 2000; 275(28): 21631 - 21638. [Abstract] [Full Text] [PDF]

				M. M. Rosenkilde, T. N. Kledal, P. J. Holst, and T. W. Schwartz Selective Elimination of High Constitutive Activity or Chemokine Binding in the Human Herpesvirus 8 Encoded Seven Transmembrane Oncogene ORF74 J. Biol. Chem., August 18, 2000; 275(34): 26309 - 26315. [Abstract] [Full Text] [PDF]

				J. A. Ballesteros, A. D. Jensen, G. Liapakis, S. G.F. Rasmussen, L. Shi, U. Gether, and J. A. Javitch Activation of the beta 2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6 J. Biol. Chem., July 27, 2001; 276(31): 29171 - 29177. [Abstract] [Full Text] [PDF]